Skip to content
OpenCapital
Get started

Journey Medical Corporation DERM Business Segments — Allocated Share Based Compensation Expense

Similar metrics at other companies

Guardian Pharmacy Services logo
GRDNCorporate — Allocated Share Based Compensation Expense
$1.86M-53.1%
OnKure Therapeutics, Inc. logo
OKURClinical Research — Allocated Share Based Compensation Expense
$2.78M+1.3%
Fulgent Genetics, Inc. logo
FLGTTherapeutic Development — Allocated Share Based Compensation Expense
$2.25M+11.5%
Lightpath Technologies logo
LPTHAllocated Share Based Compensation Expense Total
$314.07K—
EMP
EMPDCorporate And Other — Allocated Share Based Compensation Expense
$1.7M—
Nektar Therapeutics logo
NKTRAll Other Segments — Allocated Share Based Compensation Expense
$3.36M-13.9%

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M—
Free cash flow-$6.0M—

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S3×+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%—
Net margin-14.8%—
FCF margin-43%—

Returns & leverage

See full
Return on equity-36.6%—
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Journey Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's business segments — allocated share based compensation expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's business segments — allocated share based compensation expense?
Journey Medical Corporation (DERM) reported business segments — allocated share based compensation expense of $989K in Q1 2026.
How has Journey Medical Corporation's business segments — allocated share based compensation expense changed year-over-year?
Journey Medical Corporation's business segments — allocated share based compensation expense decreased by 25.2% year-over-year, from $1.32M to $989K.
What does business segments — allocated share based compensation expense mean?
Represents the non-cash expense related to equity-based awards granted to personnel within the dermatological segment. This metric is essential for understanding the true cost of talent retention and alignment with shareholder interests.